A proliferation-inducing ligand (APRIL) is a new tumor necrosis factor family member implicated in tumor cell proliferation. We investigated the role of APRIL in megakaryocytopoiesis, a developmental hematopoietic process responsible for progenitor cell differentiation to megakaryoblasts and megakaryocytes, leading to platelet formation. APRIL is not expressed in CD34+ progenitor cells from healthy donors, but it is massively up-regulated during the proliferative phase of megakaryocytic cell differentiation. Exogenous APRIL expression in primary cells increases megakaryocytic cell growth, suggesting that APRIL acts as a proliferative factor in megakaryocytopoiesis. More importantly, neutralization of endogenous APRIL was able to dramatically reduce megakaryocyte expansion and platelet production. Thus, our data provide evidence that APRIL acts as a growth factor for terminal megakaryocytopoiesis and may promote physiologic platelet production. © 2004 by The American Society of Hematology.

Bonci, D., Hahne, M., Felli, N., Peschle, C., De Maria Marchiano, R., Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis, <<BLOOD>>, 2004; 104 (10): 3169-3172. [doi:10.1182/blood-2003-11-3861] [http://hdl.handle.net/10807/113812]

Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis

De Maria Marchiano, Ruggero
2004

Abstract

A proliferation-inducing ligand (APRIL) is a new tumor necrosis factor family member implicated in tumor cell proliferation. We investigated the role of APRIL in megakaryocytopoiesis, a developmental hematopoietic process responsible for progenitor cell differentiation to megakaryoblasts and megakaryocytes, leading to platelet formation. APRIL is not expressed in CD34+ progenitor cells from healthy donors, but it is massively up-regulated during the proliferative phase of megakaryocytic cell differentiation. Exogenous APRIL expression in primary cells increases megakaryocytic cell growth, suggesting that APRIL acts as a proliferative factor in megakaryocytopoiesis. More importantly, neutralization of endogenous APRIL was able to dramatically reduce megakaryocyte expansion and platelet production. Thus, our data provide evidence that APRIL acts as a growth factor for terminal megakaryocytopoiesis and may promote physiologic platelet production. © 2004 by The American Society of Hematology.
2004
Inglese
Bonci, D., Hahne, M., Felli, N., Peschle, C., De Maria Marchiano, R., Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis, <<BLOOD>>, 2004; 104 (10): 3169-3172. [doi:10.1182/blood-2003-11-3861] [http://hdl.handle.net/10807/113812]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/113812
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 28
social impact